Journal of Developmental Therapeutics

Developmental Therapeutics, a broad area of study is about the discovery, development and delivery of new anti-cancer therapies to overcome the challenges in cancer biology. Research scientists and clinicians are collaborating closely to discover and develop novel therapeutic targets, identify new molecular targets specific to the cancer cells, and conduct early phase translational clinical trials of novel therapies.

‘Journal of Developmental Therapeutics’ primarily focuses on publishing topics ranging from laboratory-based discovery and development of cancer drugs to early-stage translational clinical trials.

‘Journal of Developmental Therapeutics’ welcome scholars across the globe to submit their original research papers fulfilling the requisite criterion. The journal also accepts review, short communication, editorial, expert review and letter to the editor.

All the manuscripts published by ‘Journal of Developmental Therapeutics’’ undergo rapid, quality and quick  review processing by eminent editorial and review team maintaining high standards and ethics of publishing.

The scholarly content published online will be freely available to every reader anywhere in the world to read, download, copy, reuse and distribute, provided that the original work is properly cited.

Authors may submit their valuable work either via the online submission form or via email to the editor’s office at submissions@asterpublications.com

Scope of the journal

The journal covers the following topics (including but not limited to the following fields).

  • Causes of cancer progression
  • Drug Discovery/Development
  • Clinical translational research
  • Pharmacology
  • Molecular and cellular biology
  • Molecular genetics
  • Synthetic chemistry
  •  biomedical engineering
  • Structural biology and molecular modeling
  • Diagnostic imaging
  • Pathology
  • Clinical investigations
  • Immunotherapy
  • Mechanisms of resistance
  • Cancer treatment strategies

 

"Journal of Developmental Therapeutics" follows the Committee on Publication Ethics (COPE) Guidelines for issues of fraud, image manipulation, and duplicate publication.

Click here for information on Publications Ethics and Guidelines.